CHGG(CHGG)
CHGG
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $198M | $146M |
| Low | $198M | $146M |
| High | $198M | $146M |
| EBITDA Avg | $56M | $52M |
| Low | $56M | $52M |
| High | $56M | $52M |
| EBIT Avg | $-12M | $-5M |
| Low | $-12M | $-5M |
| High | $-12M | $-5M |
| Net Income Avg | $-14M | $-8M |
| Low | $-14M | $-8M |
| High | $-14M | $-8M |
| EPS Avg | $-0.13 | $-0.07 |
| Low | $-0.13 | $-0.07 |
| High | $-0.13 | $-0.07 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $44M | $39M | $39M | $39M | $35M | $33M |
| Low | $44M | $39M | $39M | $39M | $35M | $33M |
| High | $44M | $39M | $39M | $39M | $35M | $33M |
| EBITDA Avg | $-7M | $-2M | $2M | $1M | $1M | $26,360 |
| Low | $-7M | $-2M | $2M | $1M | $1M | $26,360 |
| High | $-7M | $-2M | $2M | $1M | $1M | $26,360 |
| EBIT Avg | $-10M | $-6M | $-1M | $-2M | $-2M | $-3M |
| Low | $-10M | $-6M | $-1M | $-2M | $-2M | $-3M |
| High | $-10M | $-6M | $-1M | $-2M | $-2M | $-3M |
| Net Income Avg | $-10M | $-6M | $-1M | $-2M | $-2M | $-3M |
| Low | $-10M | $-6M | $-1M | $-2M | $-2M | $-3M |
| High | $-10M | $-6M | $-1M | $-2M | $-2M | $-3M |
| EPS Avg | $-0.09 | $-0.05 | $-0.01 | $-0.02 | $-0.02 | $-0.03 |
| Low | $-0.09 | $-0.05 | $-0.01 | $-0.02 | $-0.02 | $-0.03 |
| High | $-0.09 | $-0.05 | $-0.01 | $-0.02 | $-0.02 | $-0.03 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |